Nursing home advocates urge 24-hour RN staffing, PPE mandates in sweeping reform agenda
By
Alicia Lasek
Mar 16, 2021
The Care For Our Seniors Act, put forth by the AHCA and LeadingAge, seeks to address systemic issues in the nursing home sector that have been laid bare during the pandemic, including infection control...
Social isolation linked to greater COVID-19 rates in elders: Italian study
By
Alicia Lasek
May 21, 2020
Regions with a higher number of nursing facility beds and fewer household members are tied to more COVID-19 cases in people over age 80.
New U.S. poll shows high incidence of arthritis, reliance on medication for pain
Sep 13, 2022
A notable proportion of seniors rely on prescription drugs to manage their arthritis pain, but haven’t discussed the health risks with their clinicians, researchers report.
MA enrollees with dementia report poor quality of care: study
By
Alicia Lasek (f3)
May 09, 2022
Medicare Advantage plans will be more incentivized to address gaps in care if consumer care assessments include more input from enrollees with dementia, investigators say.
Seated tai chi improves functional, mental health recovery in ischemic stroke
By
Alicia Lasek
Apr 13, 2022
Patients in a modified, 12-week tai chi program saw gains in hand and arm function, balance while sitting and mental health when compared to those in a standard stroke rehab exercise program.
Online interactions may slow memory decline, study finds
By
Donna Shryer
May 17, 2021
Regular online communication with friends and family as well as in-person interaction and phone chats all work together to help maintain long-term memory among older persons, says a study conducted by...
Trotting out a new therapy for those with Parkinson’s
By
John O'Connor
Dec 15, 2020
The Human Animal Bond Research Institute announced a new research project to see whether horses might be able to help reduce symptoms among people with Parkinson’s disease.
Expanded Xofluza approval includes seniors at risk of flu complications
By
Alicia Lasek
Oct 20, 2019
The U.S. Food & Drug Administration has expanded approval of the oral antiviral drug Xofluza for people at high risk of flu complications.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Airborne coronavirus can be limited by room ventilation, open spaces: study
By
Alicia Lasek
May 04, 2020
The concentration of aerosolized coronavirus particles in two hospitals was lower in rooms with proper ventilation and after disinfection.